5.615
Prime Medicine Inc Borsa (PRME) Ultime notizie
Does Prime Medicine Inc. qualify in momentum factor screeningQuarterly Portfolio Report & Growth Focused Entry Reports - newser.com
Why Prime Medicine Inc. stock appeals to analystsWeekly Trend Recap & Community Trade Idea Sharing - newser.com
Quantitative breakdown of Prime Medicine Inc. recent moveTrade Performance Summary & AI Optimized Trade Strategies - newser.com
Is Prime Medicine Inc. stock a buy on dips2025 Volatility Report & Weekly High Momentum Picks - newser.com
News impact scoring models applied to Prime Medicine Inc.Weekly Gains Summary & Technical Analysis for Trade Confirmation - newser.com
Prime Medicine, Inc.'s (NASDAQ:PRME) 6.6% loss last week hit both individual investors who own 30% as well as institutions - simplywall.st
Prime Medicine (NASDAQ:PRME) Stock Price Down 5.8%Here's What Happened - MarketBeat
Prime Medicine (NYSE:PRME) Stock Price Down 3.4%Here's What Happened - MarketBeat
Using AI based signals to follow Prime Medicine Inc.Market Growth Summary & Short-Term Trading Opportunity Alerts - newser.com
Is it too late to sell Prime Medicine Inc.July 2025 Short Interest & Short-Term High Return Strategies - newser.com
Prime Medicine Soars 9.88% to Day High of $6.85 Amid Strong Intraday Performance - Markets Mojo
Is Prime Medicine Inc. stock entering bullish territoryWeekly Stock Report & High Return Trade Guides - newser.com
How to recover losses in Prime Medicine Inc. stockMarket Risk Report & Daily Stock Momentum Reports - newser.com
Volume spikes in Prime Medicine Inc. stock – what they mean2025 Technical Patterns & Long-Term Safe Investment Plans - newser.com
Volatility clustering patterns for Prime Medicine Inc.July 2025 Fed Impact & Low Drawdown Investment Ideas - newser.com
Prime Medicine (NASDAQ:PRME) Stock Price Up 11.6%Should You Buy? - MarketBeat
Prime Medicine (NYSE:PRME) Shares Up 7.8%Still a Buy? - MarketBeat
Prime Medicine, Inc. Hits New 52-Week High of $6.94 - Markets Mojo
Prime Medicine, Inc. Hits New 52-Week High of $6.92 - Markets Mojo
Prime Medicine to Participate in Upcoming Investor Conferences - GlobeNewswire
Prime Medicine (NASDAQ:PRME) Sets New 12-Month HighWhat's Next? - MarketBeat
Prime Medicine, Inc. (NYSE:PRME) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
What earnings revisions data tells us about Prime Medicine Inc.July 2025 Patterns & Entry and Exit Point Strategies - newser.com
Published on: 2025-10-06 02:45:47 - newser.com
Using flow based indicators on Prime Medicine Inc.Quarterly Market Review & Momentum Based Trading Signals - newser.com
Measuring Prime Medicine Inc.’s beta against major indicesJuly 2025 Earnings & Weekly Chart Analysis and Guides - newser.com
Prime Medicine Stock Price, Quotes and Forecasts | NASDAQ:PRME - Benzinga
Prime Medicine, Inc. Hits New 52-Week High of $5.82 - Markets Mojo
Short interest data insights for Prime Medicine Inc.July 2025 Trends & Stock Portfolio Risk Management - newser.com
Backtesting results for Prime Medicine Inc. trading strategiesJuly 2025 Volume & Smart Investment Allocation Insights - newser.com
Is Prime Medicine Inc a good long term investmentIPO Market Watch & Double Digit Wealth Tips - earlytimes.in
Prime Medicine (NYSE:PRME) Trading Up 8%What's Next? - MarketBeat
Prime Medicine Sees Strong Momentum Among Top Healthcare Stocks - Kalkine Media
Prime Medicine (NASDAQ:PRME) Hits New 1-Year HighTime to Buy? - MarketBeat
Prime Medicine (NASDAQ:PRME) Shares Up 3.9%Here's Why - MarketBeat
When is the best time to exit Prime Medicine Inc.July 2025 Gainers & Free Reliable Trade Execution Plans - newser.com
Septerna appoints Keith Gottesdiener to board of directors - Investing.com India
Former Prime Medicine CEO and 20+ Drug Approval Leader Keith Gottesdiener Joins Septerna's Board - Stock Titan
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):